Many of these genes appear to be specific to endometrioid endometrial tumors, as opposed to nonendometrioid endometrial tumors, including transcriptional regulators ARID1A, beta-catenin, and CTCF, indicating that there may be a connection between these mutations and estrogen signaling. Here, ARID1A is linked to endometrium neoplasm.